Correa JJ, Politis C, Rodriguez AR, Pow-Sang JM. Laparoscopic Retroperitoneal Lymph Node Dissection in the Management of Testis Cancer.
Cancer Control 2017;
14:258-64. [PMID:
17615532 DOI:
10.1177/107327480701400309]
[Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
BACKGROUND
The surgical approach to management of testis cancer has been traditionally through an open incision, but in the last decade, several centers have reported their experience with laparoscopic retroperitoneal lymph node dissection (LRPLND).
METHODS
We reviewed the English literature, summarized the outcomes, and included our initial experience with the LRPLND procedure.
RESULTS
Improvements in operative time, complications, and morbidity have occurred as surgical experience has increased. The procedure is more challenging in postchemotherapy patients. Outcomes at our institute are comparable to reported series from other institutions, and LRPLND is our current procedure of choice for RPLND.
CONCLUSIONS
LRPLND has been shown to be a safe, effective, minimally invasive procedure in the management of testicular cancer patients who require surgery to address the retroperitoneal lymph nodes.
Collapse